Fahimeh Charbgoo

1.7k total citations
20 papers, 1.3k citations indexed

About

Fahimeh Charbgoo is a scholar working on Molecular Biology, Biomedical Engineering and Materials Chemistry. According to data from OpenAlex, Fahimeh Charbgoo has authored 20 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 9 papers in Biomedical Engineering and 7 papers in Materials Chemistry. Recurrent topics in Fahimeh Charbgoo's work include Advanced biosensing and bioanalysis techniques (12 papers), RNA Interference and Gene Delivery (7 papers) and Advanced Nanomaterials in Catalysis (4 papers). Fahimeh Charbgoo is often cited by papers focused on Advanced biosensing and bioanalysis techniques (12 papers), RNA Interference and Gene Delivery (7 papers) and Advanced Nanomaterials in Catalysis (4 papers). Fahimeh Charbgoo collaborates with scholars based in Iran, United States and Germany. Fahimeh Charbgoo's co-authors include Mohammad Ramezani, Majid Darroudi, Khalil Abnous, Seyed Mohammad Taghdisi, Mona Alibolandi, Fatemeh Soltani, Mojgan Nejabat, Noor Mohammad Danesh, Aida Gholoobi and Maryam Sadat Nabavinia and has published in prestigious journals such as Angewandte Chemie International Edition, Journal of Controlled Release and Biosensors and Bioelectronics.

In The Last Decade

Fahimeh Charbgoo

19 papers receiving 1.3k citations

Peers

Fahimeh Charbgoo
Fahimeh Charbgoo
Citations per year, relative to Fahimeh Charbgoo Fahimeh Charbgoo (= 1×) peers A. Pramanik

Countries citing papers authored by Fahimeh Charbgoo

Since Specialization
Citations

This map shows the geographic impact of Fahimeh Charbgoo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fahimeh Charbgoo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fahimeh Charbgoo more than expected).

Fields of papers citing papers by Fahimeh Charbgoo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fahimeh Charbgoo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fahimeh Charbgoo. The network helps show where Fahimeh Charbgoo may publish in the future.

Co-authorship network of co-authors of Fahimeh Charbgoo

This figure shows the co-authorship network connecting the top 25 collaborators of Fahimeh Charbgoo. A scholar is included among the top collaborators of Fahimeh Charbgoo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fahimeh Charbgoo. Fahimeh Charbgoo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Charbgoo, Fahimeh, Aman Ishaqat, Junlin Chen, et al.. (2025). Remote Control of Eukaryotic Gene Expression by a Modular Ultrasound‐Responsive RNA Toolkit. Angewandte Chemie International Edition. 64(29). e202421803–e202421803.
2.
Ramezani, Mohammad, Mona Alibolandi, Fahimeh Charbgoo, et al.. (2021). A novel targeted co-delivery system for transfer of epirubicin and antimiR-10b into cancer cells through a linear DNA nanostructure consisting of FOXM1 and AS1411 aptamers. Journal of Drug Delivery Science and Technology. 63. 102521–102521. 11 indexed citations
3.
Charbgoo, Fahimeh, Fatemeh Soltani, Mona Alibolandi, et al.. (2020). Ladder-like targeted and gated doxorubicin delivery using bivalent aptamer in vitro and in vivo. Materials Science and Engineering C. 119. 111618–111618. 8 indexed citations
4.
Oroojalian, Fatemeh, Fahimeh Charbgoo, Maryam Hashemi, et al.. (2020). Recent advances in nanotechnology-based drug delivery systems for the kidney. Journal of Controlled Release. 321. 442–462. 129 indexed citations
5.
Charbgoo, Fahimeh, Mona Alibolandi, Seyed Mohammad Taghdisi, et al.. (2018). MUC1 aptamer-targeted DNA micelles for dual tumor therapy using doxorubicin and KLA peptide. Nanomedicine Nanotechnology Biology and Medicine. 14(3). 685–697. 64 indexed citations
6.
Bagheri, Elnaz, Legha Ansari, Khalil Abnous, et al.. (2018). Silica based hybrid materials for drug delivery and bioimaging. Journal of Controlled Release. 277. 57–76. 130 indexed citations
7.
Charbgoo, Fahimeh, Mojgan Nejabat, Khalil Abnous, et al.. (2018). Gold nanoparticle should understand protein corona for being a clinical nanomaterial. Journal of Controlled Release. 272. 39–53. 122 indexed citations
8.
Abnous, Khalil, Noor Mohammad Danesh, Mohammad Ramezani, et al.. (2018). Targeted delivery of doxorubicin to cancer cells by a cruciform DNA nanostructure composed of AS1411 and FOXM1 aptamers. Expert Opinion on Drug Delivery. 15(11). 1045–1052. 51 indexed citations
9.
Nabavinia, Maryam Sadat, Fahimeh Charbgoo, Mona Alibolandi, et al.. (2017). Comparison of Flow Cytometry and ELASA for Screening of Proper Candidate Aptamer in Cell-SELEX Pool. Applied Biochemistry and Biotechnology. 184(2). 444–452. 16 indexed citations
10.
Charbgoo, Fahimeh, Mohammad Ramezani, & Majid Darroudi. (2017). Bio-sensing applications of cerium oxide nanoparticles: Advantages and disadvantages. Biosensors and Bioelectronics. 96. 33–43. 127 indexed citations
11.
Danesh, Noor Mohammad, Gholamreza Karimi, Mohammad Ramezani, et al.. (2017). Ultrasensitive detection of ochratoxin A using aptasensors. Biosensors and Bioelectronics. 98. 168–179. 118 indexed citations
12.
Charbgoo, Fahimeh, et al.. (2017). Cerium oxide nanoparticles: green synthesis and biological applications. International Journal of Nanomedicine. Volume 12. 1401–1413. 243 indexed citations
13.
Charbgoo, Fahimeh, et al.. (2017). Impact of physicochemical properties of cerium oxide nanoparticles on their toxicity effects. Ceramics International. 43(17). 14572–14581. 43 indexed citations
14.
Nabavinia, Maryam Sadat, Aida Gholoobi, Fahimeh Charbgoo, et al.. (2017). Anti‐MUC1 aptamer: A potential opportunity for cancer treatment. Medicinal Research Reviews. 37(6). 1518–1539. 115 indexed citations
15.
Charbgoo, Fahimeh, Maryam Nikkhah, & Mehrdad Behmanesh. (2017). Size of single‐wall carbon nanotube affects the folate receptor‐mediated cancer cell targeting. Biotechnology and Applied Biochemistry. 65(3). 328–337. 8 indexed citations
16.
Charbgoo, Fahimeh, et al.. (2017). RNAi mediated gene silencing of ITPA using a targeted nanocarrier: Apoptosis induction in SKBR3 cancer cells. Clinical and Experimental Pharmacology and Physiology. 44(8). 888–894. 6 indexed citations
17.
Nejabat, Mojgan, Fahimeh Charbgoo, & Mohammad Ramezani. (2017). Graphene as multifunctional delivery platform in cancer therapy. Journal of Biomedical Materials Research Part A. 105(8). 2355–2367. 42 indexed citations
18.
Charbgoo, Fahimeh, Fatemeh Soltani, Seyed Mohammad Taghdisi, Khalil Abnous, & Mohammad Ramezani. (2016). Nanoparticles application in high sensitive aptasensor design. TrAC Trends in Analytical Chemistry. 85. 85–97. 64 indexed citations
19.
Charbgoo, Fahimeh, Mehrdad Behmanesh, & Maryam Nikkhah. (2014). Enhanced reduction of single‐wall carbon nanotube cytotoxicity in vitro: Applying a novel method of arginine functionalization. Biotechnology and Applied Biochemistry. 62(5). 598–605. 10 indexed citations
20.
Charbgoo, Fahimeh, et al.. (2012). Synthesis of a unique high‐performance poly‐horseradish peroxidase complex to enhance sensitivity of immunodetection systems. Biotechnology and Applied Biochemistry. 59(1). 45–49. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026